What You Should Know:
– Optimize.health raises $15.6M in Series A funding to accelerate access to and adoption of its remote patient monitoring platform.
– Optimize.Health enables improved access to care, more favorable health outcomes, and contained healthcare costs through the combination of high-quality monitoring devices and a user-friendly, HIPAA-compliant digital platform that supports two-way video calls and text conversations between patients and their clinicians.
Optimize.Health (formerly Pillsy), a Seattle, WA-based digital health startup today announced the close of a $15.6 million Series A financing round led by U.S. Venture Partners. The round also included participation from new backers Foundry Group, Daher Capital and Openview Venture Partners, as well as existing investors Bonfire Ventures and SOSV.
Remote Patient Monitoring and Engagement Platform
The ability to monitor patients remotely has never been greater, with COVID-19 having highlighted a significant need for providers to deliver care to and connect with patients outside of the office. Founded in 2015 by experienced digital health entrepreneurs Jeff LeBrun and Chuks Onwuneme, Optimize.Health makes it easy for healthcare providers to offer patient-centric, reimbursable remote monitoring. Optimize.Health’s solution offers a wide selection of affordable devices, which integrate seamlessly with its easy-to-use technology platform, empowering patients and providers alike to improve health outcomes and contain costs.
Optimize.health empowers patients + enables providers
With Optimize.health’s platform, patients are empowered to engage with their health data from the comfort of their own homes, using intuitive devices to monitor vital signs such as blood pressure, blood glucose, weight, pulse oximetry, and medication adherence. The information gleaned is then securely transmitted to their healthcare provider, who can identify symptom progression and enact early interventions where applicable.
Clinicians can use the platform to optimize revenue cycle management, ensure regulatory compliance, and seamlessly sync data to their electronic health records (EHR) system. Optimize.health’s software also automates up to 95 percent of note-taking and administrative requirements, freeing providers up to spend more time with patients.
“Challenging times can serve as a catalyst for innovation, and the COVID-19 pandemic has underscored the vital role that digital health platforms can play to help patients stay healthy,” said Jeff LeBrun, co-founder and CEO of Optimize.Health. “In addition to patients, clinics and systems have seen their businesses upended over the past few months, requiring an additional layer of resiliency. This is an unprecedented opportunity to implement lasting change in the way healthcare is delivered, and we’re delighted to have strong backing from investors that share our vision for a more accessible, more convenient and more cost-effective healthcare system.”
This funding comes on the back of a noteworthy year for optimize.health, in which the firm saw year-over-year revenue growth by over 800%, expanded its network of provider partners, and raised a $2 million seed round. The most recent injection of capital will enable the firm to expand its product and engineering teams, with the aim of adding new features and upgrading the user experience for both physicians and patients based on user feedback. In addition, it will support the growth of optimize.health’s sales and marketing operations.